The compounding pharmacist has a difficult task to maintain an understanding of not only the current state-of-science, but also the rapidly changing regulatory requirements in maintaining a compliant pharmacy. The RxList Email Discussion Group is devoted to an even-handed discussion of current and imminent changes in regulatory concerns.
There are several Email discussion groups and LinkedIn discussion boards dedicated to talking about how pharmacists would like the industry to be regulated. The RxList is not moderated for content or adherence to a particular viewpoint - only for professional, civil discussion of the topics of interest. Run by the Microbiology Network (with >25 years experieince running professional discussion groups) this conversation includes representatives from major regulatory agencies as well as practicing pharmacists.
Join your colleagues in the only discussion forum for the pharmacist that deals specifically with your colleagues' experiences with compliant compounding and regulatory concerns.
Please fill out the following information to enroll in the RxList Email List: